Last updated: October 12, 2022
Sponsor: Kessler Foundation
Overall Status: Active - Recruiting
Phase
N/A
Condition
Memory Loss
Neurologic Disorders
Multiple Sclerosis
Treatment
N/AClinical Study ID
NCT05195320
R-1164-21
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of multiple sclerosis
- 18 years of age or older
- English-speaking
- Able to provide informed consent
- Access to the internet (if needed should the groups have to be conducted online due topandemic circumstances that may limit to in-person meetings).
Exclusion
Exclusion Criteria:
- History of any other neurological illness (e.g. traumatic brain injury, epilepsy,dementia)
- Cognitive impairment that would affect my ability to fully participate in the group
- (For in-person group): Live beyond a reasonable commuting distance (50+ miles)
- Any other medical or psychological condition that, in the judgement of theinvestigators, prevents successful participation in the study
Study Design
Total Participants: 48
Study Start date:
August 01, 2022
Estimated Completion Date:
September 30, 2024
Study Description
Connect with a study center
Kessler Foundation
East Hanover, New Jersey 07036
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.